Confluence Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $785K | Buy |
11,376
+911
| +9% | +$62.9K | 0.01% | 226 |
|
2025
Q1 | $727K | Buy |
10,465
+191
| +2% | +$13.3K | 0.01% | 231 |
|
2024
Q4 | $884K | Buy |
10,274
+220
| +2% | +$18.9K | 0.01% | 209 |
|
2024
Q3 | $1.2M | Sell |
10,054
-1,210
| -11% | -$144K | 0.02% | 193 |
|
2024
Q2 | $1.61M | Buy |
11,264
+420
| +4% | +$60K | 0.02% | 187 |
|
2024
Q1 | $1.39M | Sell |
10,844
-72
| -0.7% | -$9.25K | 0.02% | 185 |
|
2023
Q4 | $1.13M | Sell |
10,916
-714
| -6% | -$73.9K | 0.02% | 191 |
|
2023
Q3 | $1.06M | Sell |
11,630
-3,764
| -24% | -$342K | 0.02% | 184 |
|
2023
Q2 | $1.25M | Sell |
15,394
-1,900
| -11% | -$154K | 0.02% | 178 |
|
2023
Q1 | $1.38M | Buy |
17,294
+88
| +0.5% | +$7K | 0.02% | 176 |
|
2022
Q4 | $1.16M | Sell |
17,206
-336
| -2% | -$22.7K | 0.02% | 190 |
|
2022
Q3 | $874K | Sell |
17,542
-1,568
| -8% | -$78.1K | 0.01% | 201 |
|
2022
Q2 | $1.07M | Sell |
19,110
-8,354
| -30% | -$466K | 0.02% | 195 |
|
2022
Q1 | $1.53M | Sell |
27,464
-3,818
| -12% | -$212K | 0.02% | 184 |
|
2021
Q4 | $1.75M | Sell |
31,282
-2,182
| -7% | -$122K | 0.02% | 187 |
|
2021
Q3 | $1.61M | Buy |
33,464
+368
| +1% | +$17.7K | 0.02% | 188 |
|
2021
Q2 | $1.39M | Buy |
33,096
+428
| +1% | +$17.9K | 0.02% | 191 |
|
2021
Q1 | $1.1M | Buy |
32,668
+2,118
| +7% | +$71.4K | 0.02% | 196 |
|
2020
Q4 | $1.07M | Sell |
30,550
-11,800
| -28% | -$412K | 0.02% | 205 |
|
2020
Q3 | $1.47M | Sell |
42,350
-1,792
| -4% | -$62.2K | 0.02% | 186 |
|
2020
Q2 | $1.45M | Sell |
44,142
-46
| -0.1% | -$1.51K | 0.02% | 187 |
|
2020
Q1 | $1.33M | Buy |
+44,188
| New | +$1.33M | 0.03% | 190 |
|